Skip to content

Observational Study of the Differences in Characteristics of the Spontaneous Electroencephalogram, Derived From the Left and Right Hemisphere in Patients With Unilateral Intracranial Tumor During Routine Anesthesia: Comparison With a Control Group Without Intracranial Pathology

Observational Study of the Differences in Characteristics of the Spontaneous Electroencephalogram, Derived From the Left and Right Hemisphere in Patients With Unilateral Intracranial Tumor During Routine Anesthesia. Comparison With a Control Group Without Intracranial Pathology.

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00936806
Acronym
VISTA
Enrollment
80
Registered
2009-07-10
Start date
2009-01-31
Completion date
2012-08-31
Last updated
2014-01-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intracranial Tumor

Keywords

Intracranial tumor patients

Brief summary

Study of the influence of brain tumor on bilateral electroencephalogram (EEG) during anaesthesia.

Interventions

None listed

Sponsors

Medtronic - MITG
CollaboratorINDUSTRY
University Hospital, Ghent
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Adult ≥ 18 - 80 years old * Able to comprehend, sign, and date the written informed consent document to participate in the clinical trial * Scheduled for procedure * ASA Class I, II or III as assigned by the anaesthesiologist

Exclusion criteria

* Allergy or inability to tolerate product * Body weight less than 70% or more than 130% of ideal body weight * Pregnant or nursing females * Participation in a clinical trial within the past 30 days * Congenital mental disability or congenital anatomical brain abnormality * A medical history of cerebrovascular accident or thrombosis * A medical history of carotic artery occlusive pathology * A medical history of degenerative cerebral pathology (MS, Dementia, ALS, para-or tetraplegia due to a traumatic disruption of the spinal cord) * A medical history of severe psychiatric pathology (Schizophrenia, severe depression, alcoholism, drug abuse) Mild depression evoked by coping with the diagnosis of cancer is not excluded * Patients with a history of epileptic insults. Patients receiving preventive anti-epileptic treatment due to the tumoral process are not excluded. * Patients with low cardiac output conditions due to pre-existing cardiac pathology (Cardiac insufficiency, valve pathology, dysrhythmia, myocardial infarction). Patients presenting with stable coronary artery disease with a normal myocardial function are not excluded) * Arterial hypertension is not an

Design outcomes

Primary

MeasureTime frame
Asymmetry of EEG extracted indices obtained from either healthy or diseased hemispheres.2 years

Secondary

MeasureTime frame
Covariates that causes asymmetry between bilaterally derived EEG.2 years

Countries

Belgium

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026